Aslera Safety "Still Open," FDA Cmte. Says; Surveillance Study Needed
Executive Summary
Genelabs/Watson Aslera should have a surveillance monitoring requirement to generate additional safety information, FDA Arthritis Advisory Committee Acting Chair Nigel Harris, MD, Morehouse School of Medicine, indicated during review of the drug.